We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QNTM market cap is 7.3M. The company's latest EPS is USD -13.7657 and P/E is -0.01.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.38M | -5.5M | -10.02M | -2.25M | -3.47M |
| Net Income | -5.49M | -1.06M | -1.39M | -1.9M | -3.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 257k | 15k | 0 | 0 | 0 |
| Operating Income | -29.86M | -28.77M | -20.23M | -13.72M | -24.13M |
| Net Income | -52.01M | -31.8M | -35.29M | -23.61M | -17.9M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.41M | 18.94M | 17.47M | 15.44M | 15.25M |
| Total Liabilities | 5.86M | 4.2M | 4.57M | 3.92M | 5.05M |
| Total Equity | 15.55M | 14.75M | 12.91M | 11.52M | 10.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 57.45M | 41.97M | 62.96M | 38.41M | 17.47M |
| Total Liabilities | 9.23M | 5.66M | 8.83M | 7.87M | 4.57M |
| Total Equity | 48.22M | 36.31M | 54.13M | 30.54M | 12.91M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.26M | -9.98M | -10.83M | -1.97M | -2.58M |
| Investing | N/A | -270k | -270k | -22k | 716k |
| Financing | -3.05M | -3.1M | -3.13M | 568k | 2.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.23M | -19.13M | -20.75M | -28.33M | -10.83M |
| Investing | -307k | 6.52M | 269k | 12.12M | -270k |
| Financing | 5.33M | 24.17M | 38.21M | -2.07M | -3.13M |
| Market Cap | 7.3M |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 1.3M |
| Average Volume (1 week) | 25.66k |
| Average Volume (1 Month) | 65.64k |
| 52 Week Change | 14.49% |
| 52 Week High | 8.86 |
| 52 Week Low | 3.50 |
| Spread (Intraday) | 0.34 (5.71%) |
| Company Name | Quantum Biopharma Ltd |
| Address |
199 bay street, suite 4000 toronto, ontario M5L 1A9 |
| Website | https://www.fsdpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
